Common use of Exempted Liens and Sale and Leaseback Transactions Clause in Contracts

Exempted Liens and Sale and Leaseback Transactions. Notwithstanding the restrictions described in Sections 5.6 and 5.7, the Company or any Subsidiary of the Company may create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted under Section 5.7, if the sum of the following does not exceed the greater of (x) 15% of Consolidated Total Assets calculated as of the day the Liens are created or assumed or the date of the Sale and Leaseback Transaction or (y) 15% of Consolidated Total Assets calculated as of the first issue date of the Notes: (i) the outstanding Indebtedness secured by such Liens (not including any Liens permitted under Section 5.6 which amount does not include any Liens permitted under the provisions of this Section 5.8); plus (ii) all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions permitted under Section 5.7 which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this Section 5.8), measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Company or such Subsidiary of the Company.

Appears in 9 contracts

Samples: Indenture (Celgene Corp /De/), Indenture (Celgene Corp /De/), Indenture (Celgene Corp /De/)

AutoNDA by SimpleDocs

Exempted Liens and Sale and Leaseback Transactions. For the benefit of the Holders of the Notes a new Section 4.9 shall be added to the Indenture as follows: “Notwithstanding the restrictions described in under Sections 5.6 and 5.74.7 or 4.8, the Company or any Subsidiary of the Company may create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted under Section 5.7as described above, if the sum of the following does not exceed the greater of (x) 1510% of Consolidated Total Assets calculated as of the day the Liens are created or assumed or the date of the Sale and Leaseback Transaction or (y) 15% of Consolidated Total Assets calculated as of the first issue date of the Notes: (i) the outstanding Indebtedness secured by such Liens (not including any Liens permitted under Section 5.6 4.7 which amount does not include any Liens permitted under the provisions of this Section 5.84.9); plus (ii) all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions permitted under Section 5.7 4.8 which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this Section 5.84.9), measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Company or such Subsidiary of the Company.

Appears in 2 contracts

Samples: First Supplemental Indenture (Biogen Inc.), First Supplemental Indenture (Biogen Idec Inc.)

Exempted Liens and Sale and Leaseback Transactions. Notwithstanding the restrictions described in Sections 5.6 and 5.7, the Company or any Subsidiary of the Company may create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted under Section 5.7, if the sum of the following does not exceed the greater of (x) 15% of Consolidated Total Assets calculated as of the day the Liens are created or assumed or the date of the Sale and Leaseback Transaction or (y) 15% of Consolidated Total Assets calculated as of the first issue date of the Notes: (i) the outstanding Indebtedness secured by such Liens (not including any Liens permitted under Section 5.6 which amount does not include any Liens permitted under the provisions of this Section 5.8); plus (ii) all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions permitted under Section 5.7 which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this Section 5.8), measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Company or such Subsidiary of the Company.. Table of Contents

Appears in 1 contract

Samples: Indenture (Celgene Corp /De/)

Exempted Liens and Sale and Leaseback Transactions. For the benefit of the Holders of the Notes a new Section 4.9 shall be added to the Indenture as follows: “Notwithstanding the restrictions described in under Sections 5.6 and 5.74.7 or 4.8, the Company or any Subsidiary of the Company may create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted under Section 5.7as described above, if the sum of the following does not exceed the greater of (x) 15% of Consolidated Total Assets calculated as of the day the Liens are created or assumed or the date of the Sale and Leaseback Transaction or (y) 15% of Consolidated Total Assets calculated as of the first issue date of the Notes: (i) the outstanding Indebtedness secured by such Liens (not including any Liens permitted under Section 5.6 4.7 which amount does not include any Liens permitted under the provisions of this Section 5.84.9); plus (ii) all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions permitted under Section 5.7 4.8 which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this Section 5.84.9), measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Company or such Subsidiary of the Company.

Appears in 1 contract

Samples: Second Supplemental Indenture (Biogen Inc.)

Exempted Liens and Sale and Leaseback Transactions. Solely for the benefit of the Securityholders of the Notes a new Section 4.09 shall be added to the Base Indenture as follows: “Notwithstanding the restrictions described in under Sections 5.6 and 5.74.07 or 4.08, the Company or any Subsidiary of the Company may create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted under Section 5.7Sections 4.07 or 4.08, if the sum of the following does not exceed the greater of (x) 15% of Consolidated Total Assets calculated as of the day the Liens are created or assumed or the date of the Sale and Leaseback Transaction or (y) 15% of Consolidated Total Assets calculated as of the first issue date of the Notes: (i) the outstanding Indebtedness secured by such Liens (not including any Liens otherwise permitted under Section 5.6 4.07 which amount does not include any Liens permitted under the provisions of this Section 5.84.09); plus (ii) all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions otherwise permitted under Section 5.7 4.08 which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this Section 5.84.09), measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Company or such Subsidiary of the Company.

Appears in 1 contract

Samples: First Supplemental Indenture (Regeneron Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Exempted Liens and Sale and Leaseback Transactions. Except as may be provided by a Future Supplemental Indenture, for the benefit of the Holders of all Securities, including the Notes, a new Section 1010 shall be added to the Indenture as follows: SECTION 1010 Exempted Liens and Sale and Leaseback Transactions. Notwithstanding the restrictions described in Sections 5.6 1008 and 5.71009, the Company or any Restricted Subsidiary of the Company may create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted under Section 5.7pursuant to Sections 1008 and 1009, if the sum of the following does not exceed the greater of (x) 155% of Consolidated Total Assets calculated as of the day the Liens are created or assumed or the date of the Sale and Leaseback Transaction or Assets: (y) 15% of Consolidated Total Assets calculated as of the first issue date of the Notes: (ia) the outstanding Indebtedness secured by such Liens (not including any Liens permitted under Section 5.6 which amount does not include 1008 other than any Liens permitted solely under the provisions of this Section 5.81010); plus plus (iib) all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions permitted under Section 5.7 which amount does not include 1009 other than any Sale and Leaseback Transactions permitted solely under the provisions of this Section 5.81010), measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Company or such Subsidiary of the CompanyRestricted Subsidiary.

Appears in 1 contract

Samples: First Supplemental Indenture (Quest Diagnostics Inc)

Exempted Liens and Sale and Leaseback Transactions. For the benefit of the Holders of the Notes a new Section 4.9 shall be added to the Base Indenture as follows: “Notwithstanding the restrictions described in under Sections 5.6 and 5.74.7 or 4.8, the Company or any Subsidiary of the Company may create or assume any Liens or enter into any Sale and Leaseback Transactions not otherwise permitted under Section 5.7as described above, if the sum of the following does not exceed the greater of (x) 1510% of Consolidated Total Assets calculated as of the day the Liens are created or assumed or the date of the Sale and Leaseback Transaction or (y) 15% of Consolidated Total Assets calculated as of the first issue date of the Notes: (i) the outstanding Indebtedness secured by such Liens (not including any Liens permitted under Section 5.6 4.7 which amount does not include any Liens permitted under the provisions of this Section 5.84.9); plus (ii) all Attributable Debt in respect of such Sale and Leaseback Transaction entered into (not including any Sale and Leaseback Transactions permitted under Section 5.7 4.8 which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this Section 5.84.9), measured, in each case, at the time such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Company or such Subsidiary of the Company.

Appears in 1 contract

Samples: Third Supplemental Indenture (Biogen Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!